In a groundbreaking industry development, IndyGeneUS and BrainRap Artificial Intelligence (BRAI) are set to merge in a historic acquisition, marking a new chapter at the forefront of medical science and AI innovation. With IndyGeneUS leading the strategic move, this merger creates a pioneering, black-owned entity in deep learning, pharmaceuticals, neuroscience hardware, and AI. By integrating BrainRap’s deep learning and AI expertise with IndyGeneUS’s contract drug manufacturing capabilities, the combined entity is poised to drive innovative gene target and drug discovery in precision medicine and cell & gene therapy markets. The strategic acquisition enhances IndyGeneUS’s mission of advancing diversity in drug and gene target discovery through cutting-edge AI technologies.
Read the full article: IndyGeneUS and BrainRap AI Form Milestone Acquisition, Pioneering the Future of AI Biochip and Genome Variant Analytics //
Source: https://www.einpresswire.com/article/698500054/indygeneus-and-brainrap-ai-form-milestone-acquisition-pioneering-the-future-of-ai-biochip-and-genome-variant-analytics